Company
Genus PLC
LON:GNS
Genus's principal activity is the global application of quantitative genetics and biotechnology to animal breeding. The company operates in five operating segments: North America, Latin America, Europe, Far East, and research and development. The research and development segment includes research, bovine product development and porcine product development,
46 stories
Archive
Barclays is the next bank under the spotlight
Barclays and Ted Baker are the notable names in the diary for Wednesday.
Genus sees profit hit by flagging Chinese pig market
The bull and pig semen company said its Chinese operations have been hit by falling pig prices and lower volumes
Genus investors squeal over China pig warning
Boss Stephen Wilson said recent volatility in the Chinese porcine market "is expected to continue for some months, creating a short-term headwind" in the new financial year
Genus flags strong growth from BRIC nations, expects slower second half
Adjusted profit before tax is expected to come in at £47-49mln for the six months to December 31
Genus higher as strong trading continues
The animal genetics specialist said trading is “ahead of expectations” and that it is likely to perform better than its previous profit growth forecasts for the 2021 financial year
Hardware & electrical equipment
Broker Liberum picks small cap, mid cap and blue chip winners for November
The FTSE 250 “looks cheap” relative to its blue-chip sibling and should outperform during the new UK lockdown, the analysts reckon
Genus downgraded to ‘hold’ by Peel Hunt over coronavirus disruption
Analysts said the Chinese market rebound is likely to offset the short-term issues in the US which are currently persisting
Genus confirms sexing semen technology infringed three patents
The litigation forms part of a long-running dispute between ABS Global Inc, Inguran, and Cytonome over the development and launch of Genus' sexed semen technology
Genus profits rise even as African Swine Fever in China hurts pig business
Revenue from the porcine business was flat even though there were fewer animal shipments in China as African Swine Fever killed pigs
City broker expects Genus to benefit from African swine fever ravaging southeast Asia
The AFS epidemic is keeping a lid on Genus’ near-term profits, but longer-term, Liberum expects pig prices and production to soar
Genus upgraded to ‘buy’ by Peel Hunt after share placing
The placing proceeds will ensure balance sheet flexibility to continue to invest in the business and to take advantage of infill acquisition opportunities, Peel Hunt analysts said
AJ Bell hits the right note on its market debut
A look at the day's major movers, featuring AJ Bell, Genus, CyanConnode, EVR Holdings, Quadrise Fuels and ImmuPharma
Genus raises £68mln through share placing
The placing price represents a 7.8% discount to the closing price of 2,386p on 6 December 2018
Genus upgraded by Kepler as African swine fever concerns abate
Kepler Chevreux analyst said that in the short term, it regards African swine fever as a manageable one-off that Genus can cope with
Genus sounds note of caution over African swine fever and trade disputes
"The successful launch of Sexcel, our innovative proprietary 21st century sexed semen product in September 2017, was a real highlight after many years of pioneering development"
FTSE ends lower as Wall St adds to ex-divi stock blues
With around half-an-hour of trading to go in London, the FTSE100 index was almost 20 points lower at 7,282, the day’s worst levels, well below an earlier peak of 7,310.
Archive
Barclays next in to bat as banking results season continues
Will Barclays' results be duff, like HSBC's, or buff, like Lloyds'?
Preview: High street in focus as Dixons Carphone updates market
Electrical retailer set to report higher sales despite EU referendum uncertainty
Risers & Fallers: Altitude, Epwin, OptiBiotix, Patisserie Holdings, Serabi Gold, UK Oil & Gas
Altitude Group hit the heights as its chairman bought 135,000 shares
Archive
Brokers pick their winners post-Brexit
Broadcaster ITV was downgraded, as was airline group IAG
Animal health firm Genus to fund gene editing programme
Genus highlighted the potential benefits of the research programme but the market focused on who is paying for it (Genus).
Week ahead: Poundland to update on Spain venture
Poundland and the Royal Mail grab the corporate headlines but the Fed will also dominate the news
Investors urged to take closer look at Astra’s lupus drug trial
AstraZeneca, Premier Oil, Man Group, and Genus are in the broker spotlight on Thursday
Archive
Clothes retailers fashionable among City analysts
Next, ASOS and Primark owner ABF were all upgraded, while Premier Farnell, Genus, Kaz Minerals, EnQuest and Wolseley were also in the broker spotlight